| TGIWX | VITSX | TGIWX / VITSX | |
| Total Expense Ratio | 0.00 | 0.03 | - |
| Annual Report Gross Expense Ratio | 0.40 | 0.03 | 1,333% |
| Fund Existence | 7 years | 28 years | - |
| Gain YTD | 9.450 | 10.560 | 89% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.89B | 2.05T | 0% |
| Annual Yield % from dividends | 1.19 | 1.12 | 106% |
| Returns for 1 year | -2.13 | 8.60 | -25% |
| Returns for 3 years | 21.65 | 60.37 | 36% |
| Returns for 5 years | 4.34 | 75.42 | 6% |
| Returns for 10 years | N/A | 209.96 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VCNIX | 26.02 | N/A | N/A |
| VALIC Company I NASDAQ-100 Index | |||
| PRWCX | 38.16 | N/A | N/A |
| T. Rowe Price Capital Appreciation | |||
| FRVFX | 44.68 | N/A | N/A |
| Franklin Small Cap Value C | |||
| RMQAX | 622.44 | N/A | N/A |
| Rydex Monthly Rbl NASDAQ-100® 2x Strt A | |||
| MCYVX | 13.05 | -0.16 | -1.21% |
| NYLI Candriam Emerging Markets Eq Inv Cl | |||